UBC8 Activators are chemical compounds that may indirectly enhance the functional activity of the E2 ubiquitin-conjugating enzyme UBC8. These compounds typically influence the ubiquitin-proteasome system (UPS), a critical pathway for protein degradation, in which UBC8 plays an integral part. UBC8 (Ubiquitin-conjugating enzyme 8) is a member of the E2 enzyme family that is involved in the ubiquitination pathway. Ubiquitination is a post-translational modification where ubiquitin, a small regulatory protein, is attached to substrate proteins, typically signaling them for degradation by the proteasome, although ubiquitination can also have non-degradative roles related to cellular signaling, DNA repair, and trafficking.
Direct UBC8 Activators interact with the enzyme in such a way as to boost its intrinsic ubiquitin-conjugating activity. This can be achieved by binding to the enzyme and inducing a conformational change that increases its affinity for ubiquitin or for the E1 ubiquitin-activating enzyme, thus facilitating the transfer of ubiquitin to UBC8. Alternatively, direct activators might increase the catalytic turnover rate of UBC8, accelerating the conjugation of ubiquitin to its substrate proteins. This type of activation is typically achieved by binding to the active site or to allosteric sites on the enzyme that regulate its activity. Indirect UBC8 Activators, on the other hand, would enhance UBC8 activity without binding directly to the enzyme. These might include chemicals that upregulate the expression of the UBC8 gene, thereby increasing the concentration of UBC8 in the cell. Other indirect activators could inhibit the action of deubiquitinating enzymes (DUBs) that remove ubiquitin from substrates, thus indirectly increasing the ubiquitination level of proteins within the cell. Additionally, compounds that modulate the activity or availability of E1 enzymes or E3 ubiquitin ligases, which work in concert with E2 enzymes like UBC8 in the ubiquitination cascade, could also serve as indirect activators.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Thalidomide indirectly enhances the functional activity of UBC8 by promoting the degradation of transcription factors, which can indirectly increase the load of ubiquitinated proteins that UBC8 can process. | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $50.00 $374.00 $2071.00 | 18 | |
Lenalidomide, similar to Thalidomide, promotes the degradation of transcription factors, indirectly enhancing the functional activity of UBC8 by increasing the load of ubiquitinated proteins that UBC8 can process. | ||||||
Pomalidomide | 19171-19-8 | sc-364593 sc-364593A sc-364593B sc-364593C sc-364593D sc-364593E | 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $100.00 $143.00 $312.00 $468.00 $1248.00 $1997.00 | 1 | |
Pomalidomide is another immunomodulatory drug that enhances the degradation of transcription factors. This can indirectly enhance the functional activity of UBC8 by increasing the load of ubiquitinated proteins. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib inhibits the 26S proteasome and increases the load of ubiquitinated proteins, indirectly enhancing UBC8's activity by increasing the demand for its ubiquitination services. | ||||||
Carfilzomib | 868540-17-4 | sc-396755 | 5 mg | $41.00 | ||
Carfilzomib, like Bortezomib, inhibits the 26S proteasome, increasing the load of ubiquitinated proteins and indirectly enhancing the functional activity of UBC8. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that increases the load of ubiquitinated proteins, indirectly enhancing UBC8's activity by increasing the number of proteins that need ubiquitination. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $158.00 | 6 | |
Celastrol is a proteostasis regulator that can increase the load of misfolded proteins, indirectly enhancing UBC8's activity by increasing the demand for its ubiquitination services. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin inhibits Hsp90, resulting in an increase in the load of misfolded proteins. This indirectly enhances UBC8's activity by increasing the demand for its ubiquitination services. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $130.00 $583.00 $4172.00 $20506.00 | 20 | |
Withaferin A can cause protein misfolding, indirectly enhancing UBC8's activity by increasing the demand for its ubiquitination services. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, causing an increase in misfolded proteins. This indirectly enhances UBC8's activity by increasing the demand for its ubiquitination services. | ||||||